Jul 21, 2026 04:06PM
Jul 8, 2026 02:34PM
Jul 8, 2026 06:06AM
Jun 2, 2026 06:43AM
Jun 1, 2026 09:59AM
Jun 1, 2026 07:31AM
May 21, 2026 05:02PM Immuneering reports 17.3-month survival in pancreatic cancer trial
May 15, 2026 07:35AM
Apr 20, 2026 09:01AM
Mar 9, 2026 08:05AM
Mar 6, 2026 04:39PM
Jan 7, 2026 04:59PM
Jan 7, 2026 04:06PM
Nov 12, 2025 06:21PM Immuneering Corporation (IMRX) Tops Q3 EPS by 3c
Oct 31, 2025 06:08AM
Sep 25, 2025 09:23AM
Sep 25, 2025 06:36AM
Sep 24, 2025 04:53PM
Sep 24, 2025 04:01PM
Sep 15, 2025 07:25AM
Sep 10, 2025 01:46PM Oppenheimer on Immuneering Corporation (IMRX): 'we believe there's additional upside with this upcoming catalyst'
Sep 3, 2025 06:13AM
Aug 25, 2025 08:02AM
Aug 25, 2025 06:40AM
Aug 13, 2025 06:01PM
Jun 25, 2025 04:15AM
Jun 18, 2025 06:36AM
Jun 17, 2025 06:01AM Immuneering Corporation (IMRX) Reports Positive Overall Survival Data for Atebimetinib
May 6, 2025 04:29PM
Mar 20, 2025 05:41PM
Mar 20, 2025 07:00AM
Feb 6, 2025 07:04AM
Jan 13, 2025 08:11AM
Jan 7, 2025 07:04AM
Dec 13, 2024 05:37AM Morgan Stanley Downgrades Immuneering Corporation (IMRX) to Underweight
Dec 12, 2024 08:00AM
Nov 25, 2024 07:08AM
Oct 15, 2024 08:01AM
Oct 3, 2024 06:12AM
Sep 16, 2024 06:48AM
Sep 12, 2024 04:06PM
Aug 19, 2024 05:26AM Mizuho Reiterates Neutral Rating on Immuneering Corporation (IMRX)

432,376 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All